Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Scientists have firmly established an association between direct-acting antiviral treatment and a lower risk of liver cancer and death.
Researchers compared liver-related death rates among Mexicans, Puerto Ricans and Cubans.
Find out if you are at risk for liver cancer even if your hepatitis C treatment was successful and you are virus-free.
This good news indicates that direct-acting antiviral (DAA) treatment is safe for those who have treated their liver cancer.
It’s best to know ahead of time how your health care will be managed. Then, you will be in control of how much information you want.
Seventy percent of liver cancer patients had either a partial response or stable disease.
Better antiretrovirals have likely mitigated HIV’s effects on the risk of end-stage liver disease and liver cancer in those with hep C.
A third of patients taking neoadjuvant Opdivo had complete responses in an early analysis.
Cabometyx is the third liver cancer drug approved in the past six months.
Those who exercise build up less liver fat, which is tied to inflammation that may give rise to cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.